West Lafayette, IN, United States of America

Melanie Janelle Bevill

This inventor holds 21 USPTO granted patents and 4 published patent applications and 4 EPO patents, primarily in Crystalline Forms. Top assignees: Amri Ssci, LLC, Salix Pharmaceuticals, Inc., Aeromics, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melanie Janelle Bevill. Retrieved from https://idiyas.com/inventor/melanie-janelle-bevill

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 4)

% Patents Active = 95.2

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 44(Granted Patents)

Location History:

Lafayette, IN (US) (2017)
West Lafayette, IN (US) (2013 - 2024)

Company Filing History:

Salix Pharmaceuticals, Inc.

Reata Pharmaceuticals, Inc.

patents

6. 1 out of 88

Alfa Wassermann, Inc.

patents

7. 1 out of 39

Ambit Biosciences Corporation

patents

8. 1 out of 575

Ono Pharmaceutical Co., Ltd.

patents

9. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Kinase Inhibitor

S1P5 Receptor

Co-Crystals

Polymorphs

Novobiocin Analog

Rifaximin

P-Coumaric Acid

Nicotinamide

Progesterone

Solid Forms

Agonistic Activity

Crystalline Forms

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12679809 - Crystalline forms and salt forms of a kinase inhibitor (2026-07-14),

2. 12459890 - Salt and crystal form of compound having agonistic activity to S1P5 receptor (2025-11-04),

3. 12091431 - Crystals (2024-09-17),

4. 12017995 - Crystalline forms and salt forms of a kinase inhibitor (2024-06-25),

5. 11725018 - Crystals (2023-08-15),

6. 11401294 - Co-crystal forms of a novobiocin analog and proline (2022-08-02),

7. 11117909 - Crystals (2021-09-14),

8. 10717755 - Co-crystal forms of a novobiocin analog and proline (2020-07-21),

9. 10098859 - Cocrystals of p-coumaric acid (2018-10-16),

10. 10004726 - Polymorphs of cocrystals of P-coumaric acid:nicotinamide (2018-06-26),

11. 9982007 - Cocrystals of progesterone (2018-05-29),

12. 9700545 - Forms of rifaximin and uses thereof (2017-07-11),

13. 9585892 - Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith (2017-03-07),

14. 9512166 - Cocrystals of progesterone (2016-12-06),

15. 9359357 - Forms of rifaximin and uses thereof (2016-06-07),

Title: **Melanie Janelle Bevill: A Pioneer in Pharmaceutical Innovations**

Introduction

Melanie Janelle Bevill is a prominent inventor based in West Lafayette, Indiana. With a remarkable portfolio of 19 patents, she has made significant contributions to the field of pharmaceuticals, particularly in developing innovative compounds and methodologies.

Latest Patents

Among her latest patents is a groundbreaking invention related to crystals, specifically for 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate. This patent includes not only the crystallization method but also the compositions and applications of these crystals. Another notable invention pertains to crystalline forms and salt forms of a kinase inhibitor, which are crucial for treating diseases associated with protein kinases. This invention outlines the pharmaceutical compositions and methods for using these solid polymorphs effectively.

Career Highlights

Throughout her impressive career, Melanie has held key positions in renowned companies such as AMRI SSCI, LLC and Salix Pharmaceuticals, Inc. Her work in these organizations has led to the development of novel pharmaceutical solutions that address various medical challenges.

Collaborations

Melanie has had the opportunity to collaborate with talented professionals in her field, including her notable coworkers Stephan D Parent and Nathan Carl Schultheiss. These collaborations have further enriched her innovative endeavors, contributing to the success of her patents.

Conclusion

Melanie Janelle Bevill's dedication to her work in pharmaceutical innovations is evident through her extensive patent portfolio. As she continues to explore new frontiers in medicine, her contributions will undoubtedly leave a lasting impact on the industry and improve patient outcomes.

Profile summary based on public USPTO records.